We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carolina Liquid Chemistries and Diazyme Enter Into Partnership

By LabMedica International staff writers
Posted on 24 Jan 2023

Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries.

In comparison to using time-consuming and labor-intensive immunoassay platforms, it is more economical to run tests on clinical chemistry analyzers. The DZ-Lite c270 is an advanced benchtop clinical chemistry analyzer with a menu of FDA-cleared, moderately complex, and innovative assays made for clinical laboratories of all sizes. The compact clinical chemistry analyzer supports 1, 2, 3, and 4-part reagent assays and has a throughput of up to 270 tests per hour. The analyzer can be used in all types of clinical laboratory settings such as reference laboratories, hospitals, and physician offices with clinical labs.


Image: DZ-Lite c270 Benchtop Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries)
Image: DZ-Lite c270 Benchtop Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries)

Related Links:
Carolina Liquid Chemistries, Corp. 
Diazyme Laboratories, Inc


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Electroporation System
Gibco CTS Xenon
New
Autoimmune Disease Test
Anti-Centromere B ELISA Test

Latest Industry News

Worldwide Initiative Aims to Develop Globally Generalizable Blood-Based Tests for Alzheimer’s Disease

Hologic Enters into Agreement with CDC for H5N1 Bird Flu Test Development

Quanterix Acquires Magnetic Bead Tech Firm Emission